EXTON, Pa., Jan. 6 /PRNewswire-FirstCall/ -- Kensey Nash Corporation today announced that it will release its earnings results for its second quarter ended December 31, 2009 at 7:30 A.M. Eastern Time on Thursday, January 28, 2010.
To participate in the teleconference call, dial 1-612-234-9960. The teleconference call will also be available for replay starting Thursday, January 28, 2010 at 11:00 A.M. Eastern Time through Thursday, February 4, 2010 at 11:59 P.M. Eastern Time by dialing 1-800-475-6701 with an access code of 140560.
About Kensey Nash Corporation. Kensey Nash Corporation is a leader in developing, manufacturing and processing resorbable biomaterial products, incorporating its proprietary collagen and synthetic polymer technology. This expertise is used to develop and commercialize its products through strategic partners. The company has an extensive range of products, which are sold in multiple medical markets, including, the cardiology, orthopedic, sports medicine, spine, endovascular and general surgery markets. The company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.
CONTACT: Joseph W. Kaufmann, President and Chief Executive Officer, Kensey
Nash Corporation, +1-484-713-2100
Web site: http://www.kenseynash.com/
